M. M. Hassan, E. Saleh, Norma Osama Abdalla, Noha Hassan Radwan, E. M. Abdelghfar
{"title":"利多卡因输注与右美托咪定输注对癌症盆腔-腹部手术致炎细胞因子和应激反应的影响:一项随机临床试验","authors":"M. M. Hassan, E. Saleh, Norma Osama Abdalla, Noha Hassan Radwan, E. M. Abdelghfar","doi":"10.35975/apic.v26i1.1765","DOIUrl":null,"url":null,"abstract":"Background & Objectives: Stress response to extensive surgeries in cancer patients results in an imbalance between the pro-inflammatory and anti-inflammatory cytokines, besides activating an inflammatory cascade. We investigated the comparative effects of intravenous infusion of dexmedetomidine and lidocaine on proinflammatory cytokines and the stress reaction. \nMethodology: A prospective randomized double blind trial was performed in National Cancer Institute. 54 patients scheduled for pelvi–abdominal cancer surgery under general anesthesia were randomly allocated to three equal groups. Lidocaine group: patients received 1.5 mg/kg loading dose of lidocaine followed by 1.5 mg/kg/h infusion; Dexmedetomidine group: received a loading dose of dexmedetomidine 1 µg/kg followed by infusion of 0.5 µg/kg/h; or Saline group: received 50 ml of normal saline followed by infusion at a rate of 10 ml/h till the end of the surgery. The primary outcome was a postoperative target level of IL–6 after 24 h. \nResults: Immediate and 24 h postoperative IL–6 and TNFα were significantly lower in both dexmedetomidine and lidocaine groups compared to the control group (P < 0.001). Dexmedetomidine group had a significantly lower IL–6 and TNFα levels compared to lidocaine group at immediate postoperative and 24 h postoperative period (P < 0.001). Dexmedetomidine and lidocaine groups had a significantly lower lactate and insulin levels compared to the control group immediately postoperatively as well as 24 h postoperatively (P < 0.001). The dexmedetomidine group had a significantly lower lactate levels compared to the lidocaine group immediately postoperatively only. The lidocaine group had lower insulin level than the control group regarding immediate postoperative period only. \nConclusion: Intraoperative infusion of dexmedetomidine or lidocaine, both attenuate the postoperative levels of proinflammatory cytokines and stress response in patients undergoing pelvi–abdominal cancer surgeries. \nClinical trial registration: The study was registered at clinicaltrials.gov (NCT 04148599). \nKey words: Lidocaine; Dexmedetomidine; Interleukins; Tumor necrosis factor-α; Stress response; Pelvi–abdominal cancer; Surgery \nAbbreviations: TNF - Tumor necrosis factor; IL – Interleukins; \nCitation: Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM. Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial. Anaesth. pain intensive care 2021;26 (1):44-52. \nDOI: 10.35975/apic.v26i1.1765 \nReceived: February 15, 2021, Reviewed: December 02, 2021, Accepted: December 05, 2021","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial\",\"authors\":\"M. M. Hassan, E. Saleh, Norma Osama Abdalla, Noha Hassan Radwan, E. M. Abdelghfar\",\"doi\":\"10.35975/apic.v26i1.1765\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background & Objectives: Stress response to extensive surgeries in cancer patients results in an imbalance between the pro-inflammatory and anti-inflammatory cytokines, besides activating an inflammatory cascade. We investigated the comparative effects of intravenous infusion of dexmedetomidine and lidocaine on proinflammatory cytokines and the stress reaction. \\nMethodology: A prospective randomized double blind trial was performed in National Cancer Institute. 54 patients scheduled for pelvi–abdominal cancer surgery under general anesthesia were randomly allocated to three equal groups. Lidocaine group: patients received 1.5 mg/kg loading dose of lidocaine followed by 1.5 mg/kg/h infusion; Dexmedetomidine group: received a loading dose of dexmedetomidine 1 µg/kg followed by infusion of 0.5 µg/kg/h; or Saline group: received 50 ml of normal saline followed by infusion at a rate of 10 ml/h till the end of the surgery. The primary outcome was a postoperative target level of IL–6 after 24 h. \\nResults: Immediate and 24 h postoperative IL–6 and TNFα were significantly lower in both dexmedetomidine and lidocaine groups compared to the control group (P < 0.001). Dexmedetomidine group had a significantly lower IL–6 and TNFα levels compared to lidocaine group at immediate postoperative and 24 h postoperative period (P < 0.001). Dexmedetomidine and lidocaine groups had a significantly lower lactate and insulin levels compared to the control group immediately postoperatively as well as 24 h postoperatively (P < 0.001). The dexmedetomidine group had a significantly lower lactate levels compared to the lidocaine group immediately postoperatively only. The lidocaine group had lower insulin level than the control group regarding immediate postoperative period only. \\nConclusion: Intraoperative infusion of dexmedetomidine or lidocaine, both attenuate the postoperative levels of proinflammatory cytokines and stress response in patients undergoing pelvi–abdominal cancer surgeries. \\nClinical trial registration: The study was registered at clinicaltrials.gov (NCT 04148599). \\nKey words: Lidocaine; Dexmedetomidine; Interleukins; Tumor necrosis factor-α; Stress response; Pelvi–abdominal cancer; Surgery \\nAbbreviations: TNF - Tumor necrosis factor; IL – Interleukins; \\nCitation: Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM. Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial. Anaesth. pain intensive care 2021;26 (1):44-52. \\nDOI: 10.35975/apic.v26i1.1765 \\nReceived: February 15, 2021, Reviewed: December 02, 2021, Accepted: December 05, 2021\",\"PeriodicalId\":7735,\"journal\":{\"name\":\"Anaesthesia, Pain & Intensive Care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anaesthesia, Pain & Intensive Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35975/apic.v26i1.1765\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia, Pain & Intensive Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35975/apic.v26i1.1765","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 1
摘要
背景与目的:肿瘤患者广泛手术后的应激反应除了激活炎症级联外,还会导致促炎和抗炎细胞因子之间的失衡。我们比较了静脉输注右美托咪定和利多卡因对促炎细胞因子和应激反应的影响。方法:在美国国家癌症研究所进行前瞻性随机双盲试验,将54例在全身麻醉下进行盆腔腹部肿瘤手术的患者随机分为三组。利多卡因组:先给药1.5 mg/kg负荷剂量,再输注1.5 mg/kg/h;右美托咪定组:右美托咪定加载剂量1µg/kg后再输注0.5µg/kg/h;生理盐水组:先给予生理盐水50 ml,再以10 ml/h的速率输注至手术结束。结果:与对照组相比,右美托咪定组和利多卡因组即刻和术后24 h的IL-6和tnf - α均显著降低(P < 0.001)。右美托咪定组术后即刻及术后24 h IL-6、TNFα水平明显低于利多卡因组(P < 0.001)。右美托咪定组和利多卡因组术后即刻及术后24 h的乳酸和胰岛素水平均显著低于对照组(P < 0.001)。右美托咪定组术后乳酸水平明显低于利多卡因组。仅术后即刻,利多卡因组胰岛素水平低于对照组。结论:术中输注右美托咪定或利多卡因均可降低盆腔癌术后患者的促炎细胞因子水平及应激反应。临床试验注册:该研究已在clinicaltrials.gov注册(NCT 04148599)。关键词:利多卡因;Dexmedetomidine;白细胞介素;肿瘤坏死因子-α;应激反应;Pelvi-abdominal癌症;外科缩略语:TNF -肿瘤坏死因子;IL -白细胞介素;引用本文:Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM。输注利多卡因与输注右美托咪定对盆腔腹部肿瘤手术中促炎细胞因子和应激反应的影响:一项随机临床试验。Anaesth。疼痛重症监护2021;26(1):44-52。收稿日期:2021年2月15日,审稿日期:2021年12月02日,收稿日期:2021年12月05日
Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial
Background & Objectives: Stress response to extensive surgeries in cancer patients results in an imbalance between the pro-inflammatory and anti-inflammatory cytokines, besides activating an inflammatory cascade. We investigated the comparative effects of intravenous infusion of dexmedetomidine and lidocaine on proinflammatory cytokines and the stress reaction.
Methodology: A prospective randomized double blind trial was performed in National Cancer Institute. 54 patients scheduled for pelvi–abdominal cancer surgery under general anesthesia were randomly allocated to three equal groups. Lidocaine group: patients received 1.5 mg/kg loading dose of lidocaine followed by 1.5 mg/kg/h infusion; Dexmedetomidine group: received a loading dose of dexmedetomidine 1 µg/kg followed by infusion of 0.5 µg/kg/h; or Saline group: received 50 ml of normal saline followed by infusion at a rate of 10 ml/h till the end of the surgery. The primary outcome was a postoperative target level of IL–6 after 24 h.
Results: Immediate and 24 h postoperative IL–6 and TNFα were significantly lower in both dexmedetomidine and lidocaine groups compared to the control group (P < 0.001). Dexmedetomidine group had a significantly lower IL–6 and TNFα levels compared to lidocaine group at immediate postoperative and 24 h postoperative period (P < 0.001). Dexmedetomidine and lidocaine groups had a significantly lower lactate and insulin levels compared to the control group immediately postoperatively as well as 24 h postoperatively (P < 0.001). The dexmedetomidine group had a significantly lower lactate levels compared to the lidocaine group immediately postoperatively only. The lidocaine group had lower insulin level than the control group regarding immediate postoperative period only.
Conclusion: Intraoperative infusion of dexmedetomidine or lidocaine, both attenuate the postoperative levels of proinflammatory cytokines and stress response in patients undergoing pelvi–abdominal cancer surgeries.
Clinical trial registration: The study was registered at clinicaltrials.gov (NCT 04148599).
Key words: Lidocaine; Dexmedetomidine; Interleukins; Tumor necrosis factor-α; Stress response; Pelvi–abdominal cancer; Surgery
Abbreviations: TNF - Tumor necrosis factor; IL – Interleukins;
Citation: Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM. Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial. Anaesth. pain intensive care 2021;26 (1):44-52.
DOI: 10.35975/apic.v26i1.1765
Received: February 15, 2021, Reviewed: December 02, 2021, Accepted: December 05, 2021